Asia Pacific Digital Therapeutics Market is segmented By Product Type (Software, Devices, Others), By Application (Diabetes, Obesity, Cardiovascular Diseases (CVD), Central Nervous System (CNS) Diseases, Respiratory Diseases, Smoking Cessation, Gastrointestinal Disorders (GID), Others), By Sales Channel (Business-to-Business (B2B), Business-to-Consumer (B2C)), and By Country ( China, India, Japan, Australia) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031.
Market Overview
Asia Pacific Digital Therapeutics Market is expected to grow at a CAGR of 23.30% during the forecast period 2024-2031.
Digital therapeutics is a healthcare solution and treatment option that uses digital technologies to cure patients with medical or psychological problems. It offers a new approach to disease management by using high-quality software and systems to assist patients in monitoring their health conditions at home. These solutions use the internet infrastructure, smartphones, and advanced technologies such as artificial intelligence (AI), machine learning, and big data analytics to customize the treatment to the patient.
The digital therapeutics market includes various products such as telemedicine platforms, apps, wearable devices, and others. Currently, there are many healthcare apps and wearable devices that are easily accessible worldwide.
Market Scope
| Metrics | Details |
| CAGR | 23.30% |
| Size Available for Years | 2022-2031 |
| Forecast Period | 2024-2031 |
| Data Availability | Value (US$) |
| Segments Covered | Product Type, Application, Sales Channel, and Country |
| Countries Covered | China, India, Japan, Australia |
| Largest Country | Japan |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report - Request for Sample
Market Dynamics
The Increasing usage of smartphones & tablets
The Asia Pacific region is witnessing significant growth in the digital therapeutics market. This growth is primarily driven by the increasing usage of smartphones and tablets and a year-on-year rise in the incidence of chronic diseases. Technological advancements in mobile healthcare and improved drug compliance have further boosted the digital therapeutics market in this region. Additionally, there is a growing demand for PDTx due to their profitability.
The Rise in ageing population suffering from chronic diseases is expected to contribute to this growth
The market for prescription digital therapeutics is expected to grow globally due to factors such as easy accessibility, patient comfort, and the potential to influence behavioural change. Additionally, the rise in aging population suffering from chronic diseases is expected to contribute to this growth. Moreover, government initiatives aimed at improving healthcare services and infrastructure in various regions around the world further encourage the growth of this market.
Impact of COVID-19 on the Asia-Pacific digital therapeutics market
The COVID-19 outbreak has disrupted healthcare systems in APAC, leading to a focus on strengthening infrastructure. The pandemic has increased awareness of digital health, mental illness, and drug abuse, positively impacting the growth of the digital therapeutics market. The nationwide lockdown has resulted in unhealthy lifestyles and increased mental stress, leading to the demand for therapeutic devices and software.
Market Segment Analysis
The Asia Pacific Digital Therapeutics Market is segmented into product type, application, sales channel and country
By Product Type
- Software
- Devices
- Others
By Application
- Diabetes
- Obesity
- Cardiovascular Diseases (CVD)
- Central Nervous System (CNS) Diseases
- Respiratory Diseases
- Smoking Cessation
- Gastrointestinal Disorders (GID)
- Others
By Sales Channel
- Business-to-Business (B2B)
- Employer
- Healthcare Providers
- Payers
- Pharmaceutical Companies
- Others
- Business-to-Consumer (B2C)
- Patient
- Caregiver
By Country
- China
- India
- Japan
- Australia
Market Geographical Share
The Asia Pacific Digital Therapeutics Market can be segmented into China, India, Japan, and Australia.
The Asia Pacific market is projected to have substantial growth over the forecast period from a geographical perspective. Within the Asia-Pacific (APAC) region, it is anticipated that the Chinese market will exhibit a robust growth rate from 2024 to 2031. The Indian market is expected to see substantial growth throughout the projected timeframe. The Indian market is seeing an increase in its size due to the proliferation of hospital applications and the rising incidence of chronic illnesses.
The digital therapeutics market in Japan and Australia is projected to have significant growth over the forecast period, primarily due to the increasing use of tablets and smartphones.
Market Companies
Companies like Fitbit, Inc. (Twine Health, Inc.), Medtronic Plc., Novartis International AG (Pear Therapeutics, Inc.), Resmed, Inc. (Propeller Health), Voluntis, Inc., Ada Health GmbH, Cognifit ltd, Caterna Vision GmbH, Sonormed GmbH, and Kaia Health are playing a leading role in the APAC digital therapeutics market.
